查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1577518

女性科技全球市場

FemTech
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球女性科技市場預計將達到 1,070 億美元

預計 2023 年全球女性科技市場規模為 366 億美元，預計到 2030 年將達到 1,070 億美元，2023-2030 年分析期間複合年成長率為 16.6%。 Femtech 設備是本報告分析的細分市場之一，預計複合年成長率為 16.8%，到分析期結束時將達到 388 億美元。分析期間，女性科技軟體產業的複合年成長率預計為 18.1%。

美國市場預計將成長96億美元，中國複合年成長率為15.5%

到 2023 年，美國女性科技市場預計將達到 96 億美元。中國作為世界第二大經濟體，預計2030年市場規模將達163億美元，2023-2030年分析期間複合年成長率為15.5%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 15.2% 和 14.2%。在歐洲，德國的複合年成長率預計約為 12.1%。

全球女性科技市場—主要趨勢與促進因素總結

為什麼女性科技成為全球醫療保健領域的主要力量？

Femtech 是女性科技的縮寫，專注於滿足女性健康和保健需求的技術和創新，是全球醫療保健領域快速發展的技術。該市場包括數位健康解決方案、穿戴式裝置、行動應用程式、診斷工具，特別是針對生殖健康、懷孕護理、更年期、月經健康、不孕症、性健康和一般健康等問題的產品。隨著人們對女性獨特醫療保健需求的認知不斷增強，女性科技正成為提供傳統上在醫療保健創新中代表性不足的解決方案的重要參與者。

女性科技興起的主要原因之一是，在行動科技、穿戴式裝置和數位健康平台等進步的支持下，女性對其健康的影響力不斷增強。女性擴大使用科技來追蹤她們的月經週期、監測她們的生育能力、管理她們的懷孕、獲得遠端醫療服務，並對她們的醫療決策有更大的自主權。此外，傳統醫療保健提供者長期以來一直未能解決許多女性健康問題，例如更年期和月經失調，這使得女性科技解決方案目前正在解決這一空白。對滿足女性獨特生物需求的個人化醫療解決方案的需求激增，正在推動女性科技的快速成長。

此外，社會向性別平等的轉變和對婦女健康問題認知的提高正在提高該市場的知名度。公共衛生宣傳活動、領導職位中女性人數的增加以及女性企業家的崛起都有助於推動針對女性的創新醫療保健解決方案的發展。隨著政府、醫療保健提供者和投資者認知到更有效地解決女性健康問題所帶來的經濟和社會效益，女性科技在全球範圍內獲得了巨大的關注，並為更全面的醫療保健鋪平了道路。

科技進步如何增強女性科技解決方案？

科技進步正在徹底改變女性科技，提高女性健康解決方案的功能性、可及性和個人化。女性科技最重要的創新之一是行動醫療(行動醫療 ) 應用程式的興起，這些應用程式允許女性追蹤和管理其生殖生活的各個方面。 Clue、Flo 和 Natural Cycles 等應用程式可讓使用者監測月經週期、預測排卵、追蹤症狀，並深入了解自己的生育能力和整體健康狀況。這些應用程式使用人工智慧 (AI) 和機器學習演算法來分析資料並提供個人化建議，幫助女性了解其獨特的健康模式。此外，這些數位平台為女性提供量身定做的健康見解，使她們能夠就避孕、生育治療和一般健康做出明智的決定。

穿戴式科技是女性科技進步的另一個主要領域。智慧手環和貼片等穿戴式裝置配備了感測器，可以監測生命徵象、荷爾蒙水平和其他與女性健康相關的生理指標。例如，Ava 等穿戴式裝置使用生理資料來追蹤受孕窗口，並為女性提供一種非侵入性的方式來管理其生育計畫。由於生物感測技術的進步，這些設備變得越來越複雜，可以即時監測直接影響生殖和整體健康的因素，例如荷爾蒙波動、壓力水平甚至睡眠模式。穿戴式裝置和智慧型手機應用程式整合還透過資料同步來改善用戶體驗，以進行全面的健康追蹤和分析。

遠端醫療和遠距醫療保健服務的進步正在進一步擴大女性科技市場。虛擬醫療平台使女性更容易獲得醫療諮詢，特別是在孕產婦護理、性健康和更年期管理等領域。專注於女性健康的遠端醫療服務為患者提供了一種便捷的方式來獲得專家建議、處方箋和治療方案，而無需親自去醫生辦公室。這種可近性對於生活在農村和服務不足地區的婦女尤其有價值，因為這些地區獲得專門醫療保健的機會可能有限。隨著遠端醫療和人工智慧診斷的興起，女性科技正在透過使其更加方便、個人化和隨時可用來提高女性護理品質。

不斷變化的消費者偏好和社會趨勢如何塑造女性科技市場？

不斷變化的消費者偏好和社會趨勢在塑造全球女性科技市場方面發揮關鍵作用。尤其是，越來越多的女性正在尋求個人化、便利且容易取得的醫療保健解決方案。這一趨勢的關鍵促進因素之一是人們對自我護理和預防醫學日益成長的興趣。女性在管理自己的健康方面變得更加積極主動，並正在尋找工具來追蹤、了解和改善她們的身心健康。 Femtech 解決方案，例如生育追蹤應用程式、經期管理工具和更年期支援設備，提供量身定做的醫療保健選項，幫助女性管理自己的獨特需求，而不必僅依賴傳統的醫療保健提供者，這符合這一趨勢。

對特定性別醫療保健挑戰的認知不斷提高也影響著消費者的行為。幾十年來，月經失調、子宮內膜異位症和更年期等女性健康問題要么診斷不足，要么調查不足。醫療保健服務方面的這種差距導致了對專門針對女性需求的專業解決方案的需求。從荷爾蒙監測穿戴裝置到骨盆底肌肉訓練器，消費者需要能夠為這些問題提供真正解決方案的產品和服務，從而開闢女性科技創新的新途徑。這些趨勢也體現在對幫助人們管理性健康的產品的需求上，例如智慧凱格爾訓練器和提供性健康教育的應用程式，所有這些都有助於更全面的女性健康管理。

包括醫療保健在內的所有領域的性別平等和代表性社會運動也是塑造女性科技市場的重要趨勢。女性企業家、創新者和醫療保健專業人員在開發解決婦女健康問題的產品和服務方面處於主導，並確保這些需求在更廣泛的醫療保健系統中得到優先考慮。隨著投資者認知到該市場開拓的潛力和盈利，對女性科技新興企業的創業投資投資也在增加。此外，圍繞生殖權利、醫療保健中的性別平等以及消除女性健康問題的爭論使女性科技公司更容易提高自己的形象並更有效地行銷其產品。

此外，數位平台和社交媒體的興起使女性科技公司能夠直接與消費者互動，從而創建社區主導的醫療保健方法。許多女性科技品牌正在利用社群媒體來教育和增強女性健康，解決月經、不孕和更年期等傳統禁忌話題。公司和消費者之間的這種公開對話正在創造一個更具包容性的環境，讓女性更輕鬆地討論自己的健康需求並尋求適合她們的解決方案。消費者偏好的這些變化，加上性別平等和透明度的社會趨勢，正在推動女性科技市場的成長，並為女性創造更個人化的醫療保健體驗。

全球女性科技市場成長的驅動力是什麼？

全球女性科技市場的成長受到幾個關鍵因素的推動，包括增加對女性健康解決方案的投資、技術創新以及消費者對個人化醫療保健的需求不斷成長。這一成長的關鍵驅動力之一是創業投資和醫療保健投資者的關注和資金籌措的增加，他們認知到女性科技的巨大市場潛力。從歷史上看，女性健康在醫療保健創新中一直資金不足且代表性不足，但近年來，隨著行業認知到對專業產品和服務的需求，投資激增。專注於生殖健康、孕產婦護理和更年期管理的女性科技新興企業正在獲得巨大的關注，多家公司籌集了大量資金來開發尖端產品並擴大其市場佔有率。

成長的另一個主要驅動力是人們對婦女健康問題的認知不斷增強以及向預防保健的轉變。穿戴式科技和行動醫療應用程式的興起使女性能夠透過追蹤月經週期、監測生育能力和即時管理慢性疾病來掌控自己的健康。這些技術使婦女能夠做出明智的醫療保健決定，並在需要時尋求早期干預，減輕傳統醫療保健系統的負擔並改善長期健康驅動結果。對預防性醫療保健解決方案的需求，特別是在不孕症管理和懷孕護理等領域，預計將推動女性科技市場的進一步擴張。

全球對改善女性健康日益成長的興趣也在推動女性科技的採用方面發揮關鍵作用。世界各地的政府和醫療保健組織正在發起旨在解決婦女健康挑戰的舉措，從改善生殖保健服務到提供更好的孕產婦護理服務。在獲得醫療保健機會有限的發展中地區尤其如此，而女性科技解決方案提供了一種有效的方法來彌補女性醫療保健方面的差距。提供遠端醫療、教育資源和健康追蹤工具的行動醫療平台在這些地區特別有價值，可以推動市場成長並改善健康公平。

最後，健康和個人化醫療保健的社會趨勢對女性科技市場的成長做出了重大貢獻。隨著消費者越來越重視自我護理和個人化健康解決方案，女性科技產品正成為各年齡層女性健康習慣的重要組成部分。從生育追蹤設備和應用程式到荷爾蒙監測穿戴式裝置和骨盆健康解決方案，femtech 提供的產品可提供即時見解和個人化護理，幫助女性掌控自己的健康。對個人化、技術主導的醫療保健的需求不斷成長，正在推動女性科技的創新和投資，使其在全球市場上持續成長。

由於投資增加、技術進步、消費者對預防性和個人化護理的需求不斷成長以及全球對改善女性健康的興趣日益濃厚，全球女性科技市場正在迅速擴張。隨著醫療保健產業繼續優先考慮女性健康並解決長期存在的照護差距，女性科技在改變世界各地女性醫療保健的未來方面可以發揮重要作用。

受訪企業範例（共39家）

  • Aavia
  • Allara Health
  • Athena Feminine Technologies, Inc.
  • BioWink GmbH（Clue）
  • Bloomlife
  • Canopie Inc.
  • Coroflo Limited
  • Flo Health
  • Glow Inc.
  • LunaJoy

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他領域

第4章 比賽

簡介目錄
Product Code: MCP24365

Global FemTech Market to Reach US$107.0 Billion by 2030

The global market for FemTech estimated at US$36.6 Billion in the year 2023, is expected to reach US$107.0 Billion by 2030, growing at a CAGR of 16.6% over the analysis period 2023-2030. FemTech Devices, one of the segments analyzed in the report, is expected to record a 16.8% CAGR and reach US$38.8 Billion by the end of the analysis period. Growth in the FemTech Software segment is estimated at 18.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$9.6 Billion While China is Forecast to Grow at 15.5% CAGR

The FemTech market in the U.S. is estimated at US$9.6 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$16.3 Billion by the year 2030 trailing a CAGR of 15.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 15.2% and 14.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.1% CAGR.

Global FemTech Market – Key Trends & Drivers Summarized

Why Is FemTech Gaining Major Traction in the Global Healthcare Landscape?

FemTech, short for female technology, has emerged as a rapidly growing segment in the global healthcare landscape, focusing on technology and innovations that cater to women’s health and wellness needs. This market includes digital health solutions, wearables, mobile apps, diagnostic tools, and products that specifically address issues such as reproductive health, pregnancy care, menopause, menstrual health, fertility, sexual health, and general wellness. With increasing awareness of women’s unique healthcare needs, FemTech is becoming a critical player in providing solutions that have been historically underrepresented in healthcare innovation.

One of the key reasons for the rise of FemTech is the increasing empowerment of women to take control of their health, supported by advancements in mobile technology, wearable devices, and access to digital health platforms. Women are increasingly turning to technology to track menstrual cycles, monitor fertility, manage pregnancy, and access telemedicine services, giving them greater autonomy over their healthcare decisions. Additionally, many women’s health issues, such as menopause or menstrual disorders, have long been underserved by traditional healthcare providers, leaving a gap that FemTech solutions are now addressing. This surge in demand for personalized healthcare solutions that cater to women’s unique biological needs is driving the rapid growth of FemTech.

Furthermore, societal shifts toward gender equality and increased focus on women’s health issues have brought more attention to this market. Public health campaigns, greater representation of women in leadership positions, and the rise of women entrepreneurs have all contributed to the push for more innovative healthcare solutions for women. As governments, healthcare providers, and investors recognize the economic and social benefits of addressing women’s health more effectively, FemTech is gaining significant traction worldwide, paving the way for more inclusive healthcare technologies.

How Are Technological Advancements Enhancing FemTech Solutions?

Technological advancements are revolutionizing FemTech by improving the functionality, accessibility, and personalization of women’s health solutions. One of the most significant innovations in FemTech has been the rise of mobile health (mHealth) apps that allow women to track and manage various aspects of their reproductive health. Apps like Clue, Flo, and Natural Cycles enable users to monitor their menstrual cycles, predict ovulation, and track symptoms, offering insights into fertility and overall health. These apps use artificial intelligence (AI) and machine learning algorithms to analyze data and provide personalized recommendations, making it easier for women to understand their unique health patterns. Additionally, these digital platforms empower women to make informed decisions about contraception, fertility treatments, and general health by providing them with tailored health insights.

Wearable technology is another major area of advancement within FemTech. Wearable devices, such as smart bracelets and patches, now come equipped with sensors that monitor vital signs, hormone levels, and other physiological metrics related to women’s health. For example, wearables like Ava use physiological data to track fertility windows, offering non-invasive ways for women to manage fertility planning. These devices are becoming more sophisticated, with advancements in biosensing technologies that allow for real-time monitoring of hormone fluctuations, stress levels, and even sleep patterns—factors that directly impact reproductive and overall health. The integration of wearables with smartphone apps also enhances user experience by syncing data for comprehensive health tracking and analysis.

Advances in telemedicine and remote healthcare services are further expanding the FemTech market. Virtual healthcare platforms are making it easier for women to access medical consultations, especially in areas such as prenatal care, sexual health, and menopause management. Telemedicine services that specialize in women’s health offer a convenient way for patients to receive expert advice, prescriptions, and treatment options without needing to visit a clinic in person. This accessibility is particularly valuable for women living in rural or underserved areas, where access to specialized healthcare may be limited. With the rise of telemedicine and AI-powered diagnostics, FemTech is improving the quality of care for women by making it more convenient, personalized, and readily available.

How Are Changing Consumer Preferences and Societal Trends Shaping the FemTech Market?

Changing consumer preferences and societal trends are playing a crucial role in shaping the global FemTech market, particularly as more women demand personalized, convenient, and accessible healthcare solutions. One of the key drivers of this trend is the increasing focus on self-care and preventive health. Women are becoming more proactive about managing their health, seeking tools that enable them to track, understand, and improve their physical and mental well-being. FemTech solutions, such as fertility tracking apps, period management tools, and menopause support devices, align with this trend by offering customized healthcare options that help women manage their unique needs without relying solely on traditional healthcare providers.

The increasing awareness of gender-specific healthcare challenges is also influencing consumer behavior. For decades, women's health issues, such as menstrual disorders, endometriosis, and menopause, were either underdiagnosed or under-researched. This gap in healthcare services has led to a demand for specialized solutions that cater specifically to women's needs. Consumers are seeking products and services that provide real solutions to these issues, from hormone-monitoring wearables to pelvic floor trainers, which have opened up new avenues for FemTech innovation. These trends are also reflected in the demand for products that help manage sexual health, such as smart Kegel trainers or apps that provide sexual health education, all of which contribute to more comprehensive women’s health management.

The societal push for gender equality and representation in all sectors, including healthcare, is another important trend shaping the FemTech market. Women entrepreneurs, innovators, and healthcare professionals are leading the charge in developing products and services that cater to women’s health, ensuring that these needs are prioritized within the broader healthcare system. This has also resulted in more venture capital investment into FemTech startups, as investors recognize the untapped potential and profitability of the market. Additionally, discussions around reproductive rights, gender parity in healthcare, and the destigmatization of women’s health issues have made it easier for FemTech companies to gain visibility and market their products more effectively.

Moreover, the rise of digital platforms and social media has enabled FemTech companies to engage directly with consumers, creating a community-driven approach to healthcare. Many FemTech brands use social media to educate and empower women about their health, addressing topics that have historically been considered taboo, such as menstruation, fertility, and menopause. This open dialogue between companies and consumers is creating a more inclusive environment, where women feel more comfortable discussing their health needs and seeking solutions tailored specifically for them. These changing consumer preferences, coupled with societal trends toward gender equality and transparency, are driving growth in the FemTech market and creating a more personalized healthcare experience for women.

What Is Driving the Growth of the Global FemTech Market?

The growth of the global FemTech market is being driven by several key factors, including increased investment in women’s health solutions, technological innovation, and rising consumer demand for personalized healthcare. One of the primary drivers of this growth is the increasing attention and funding from venture capitalists and healthcare investors who recognize the significant market potential in FemTech. Historically, women’s health has been underfunded and underrepresented in healthcare innovation, but recent years have seen a surge in investment as the industry acknowledges the need for specialized products and services. FemTech startups focusing on reproductive health, maternal care, and menopause management have gained substantial traction, with several companies securing large rounds of funding to develop cutting-edge products and expand their market presence.

Another significant driver of growth is the expanding awareness of women’s health issues and the shift toward preventive care. With the rise of wearable technology and mHealth apps, women are increasingly able to take control of their health by tracking their menstrual cycles, monitoring fertility, and managing chronic conditions in real time. These technologies empower women to make informed healthcare decisions and seek early interventions when needed, reducing the burden on traditional healthcare systems and promoting long-term health outcomes. The demand for preventive health solutions, particularly in areas like fertility management and pregnancy care, is expected to drive further expansion of the FemTech market.

The growing global focus on improving women’s health outcomes is also playing a key role in driving FemTech adoption. Governments and healthcare organizations worldwide are launching initiatives aimed at addressing women’s health challenges, from improving access to reproductive healthcare to providing better maternal care services. This is particularly evident in developing regions where access to healthcare is limited, and FemTech solutions offer an efficient way to bridge the gap in women’s healthcare. Mobile health platforms that provide access to telemedicine, educational resources, and health tracking tools are particularly valuable in these areas, driving market growth and improving health equity.

Lastly, societal trends toward wellness and personalized healthcare are significantly contributing to the growth of the FemTech market. As consumers increasingly prioritize self-care and personalized health solutions, FemTech products are becoming a key component of wellness routines for women of all ages. From fertility tracking devices and apps to hormone-monitoring wearables and pelvic health solutions, FemTech offers products that provide real-time insights and customized care, making it easier for women to manage their health on their own terms. This rising demand for personalized and tech-driven healthcare is encouraging innovation and investment in FemTech, positioning it for continued growth in the global market.

The combination of increased investment, technological advancements, growing consumer demand for preventive and personalized care, and a global focus on improving women’s health outcomes is driving the rapid expansion of the global FemTech market. As the healthcare industry continues to prioritize women's health and address long-standing gaps in care, FemTech is poised to play a pivotal role in transforming the future of healthcare for women worldwide.

Select Competitors (Total 39 Featured) -

  • Aavia
  • Allara Health
  • Athena Feminine Technologies, Inc.
  • BioWink GmbH (Clue)
  • Bloomlife
  • Canopie Inc.
  • Coroflo Limited
  • Flo Health
  • Glow Inc.
  • LunaJoy

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • FemTech - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Focus on Womens Health and Wellness Propels Growth in FemTech Market
    • Case Overview: Growth in Digital Health Platforms Fuels Adoption of FemTech Solutions
    • Technological Innovations in Fertility Tracking and Reproductive Health Strengthen Business Case for FemTech
    • Focus on Menstrual Health and Hormonal Wellness Drives Market Adoption of FemTech Apps
    • Increasing Investments in Women-Centric Startups Expands Opportunities for FemTech Innovations
    • Case Overview: Rising Popularity of Telemedicine and Virtual Healthcare Bodes Well for FemTech Market Growth
    • Focus on Maternal and Prenatal Care Strengthens Market Adoption of FemTech Solutions
    • Focus on Sexual Health and Wellness Drives Innovation in FemTech Products and Services
    • Increasing Use of FemTech for Mental Health and Wellbeing Strengthens Market Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World FemTech Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for FemTech by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for FemTech by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for FemTech by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Consumer Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Consumer Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Consumer Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Direct-to-Consumer End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Direct-to-Consumer End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Direct-to-Consumer End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Fertility Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Fertility Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Fertility Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: World 16-Year Perspective for Diagnostic Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • FemTech Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for FemTech by Offering - Devices, Software, Consumer Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for FemTech by Offering - Devices, Software, Consumer Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for FemTech by Offering - Percentage Breakdown of Value Sales for Devices, Software, Consumer Products and Services for the Years 2014, 2024 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for FemTech by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for FemTech by Offering - Devices, Software, Consumer Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for FemTech by Offering - Devices, Software, Consumer Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for FemTech by Offering - Percentage Breakdown of Value Sales for Devices, Software, Consumer Products and Services for the Years 2014, 2024 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for FemTech by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
  • JAPAN
    • FemTech Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for FemTech by Offering - Devices, Software, Consumer Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for FemTech by Offering - Devices, Software, Consumer Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for FemTech by Offering - Percentage Breakdown of Value Sales for Devices, Software, Consumer Products and Services for the Years 2014, 2024 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for FemTech by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
  • CHINA
    • FemTech Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 53: China Recent Past, Current & Future Analysis for FemTech by Offering - Devices, Software, Consumer Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: China Historic Review for FemTech by Offering - Devices, Software, Consumer Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: China 16-Year Perspective for FemTech by Offering - Percentage Breakdown of Value Sales for Devices, Software, Consumer Products and Services for the Years 2014, 2024 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: China Historic Review for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: China 16-Year Perspective for FemTech by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
  • EUROPE
    • FemTech Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 59: Europe Recent Past, Current & Future Analysis for FemTech by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for FemTech by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for FemTech by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for FemTech by Offering - Devices, Software, Consumer Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for FemTech by Offering - Devices, Software, Consumer Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for FemTech by Offering - Percentage Breakdown of Value Sales for Devices, Software, Consumer Products and Services for the Years 2014, 2024 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for FemTech by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
  • FRANCE
    • FemTech Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 68: France Recent Past, Current & Future Analysis for FemTech by Offering - Devices, Software, Consumer Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: France Historic Review for FemTech by Offering - Devices, Software, Consumer Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: France 16-Year Perspective for FemTech by Offering - Percentage Breakdown of Value Sales for Devices, Software, Consumer Products and Services for the Years 2014, 2024 & 2030
    • TABLE 71: France Recent Past, Current & Future Analysis for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: France Historic Review for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: France 16-Year Perspective for FemTech by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
  • GERMANY
    • FemTech Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 74: Germany Recent Past, Current & Future Analysis for FemTech by Offering - Devices, Software, Consumer Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for FemTech by Offering - Devices, Software, Consumer Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Germany 16-Year Perspective for FemTech by Offering - Percentage Breakdown of Value Sales for Devices, Software, Consumer Products and Services for the Years 2014, 2024 & 2030
    • TABLE 77: Germany Recent Past, Current & Future Analysis for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Germany 16-Year Perspective for FemTech by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 80: Italy Recent Past, Current & Future Analysis for FemTech by Offering - Devices, Software, Consumer Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for FemTech by Offering - Devices, Software, Consumer Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Italy 16-Year Perspective for FemTech by Offering - Percentage Breakdown of Value Sales for Devices, Software, Consumer Products and Services for the Years 2014, 2024 & 2030
    • TABLE 83: Italy Recent Past, Current & Future Analysis for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Italy 16-Year Perspective for FemTech by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • FemTech Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 86: UK Recent Past, Current & Future Analysis for FemTech by Offering - Devices, Software, Consumer Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for FemTech by Offering - Devices, Software, Consumer Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: UK 16-Year Perspective for FemTech by Offering - Percentage Breakdown of Value Sales for Devices, Software, Consumer Products and Services for the Years 2014, 2024 & 2030
    • TABLE 89: UK Recent Past, Current & Future Analysis for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: UK 16-Year Perspective for FemTech by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for FemTech by Offering - Devices, Software, Consumer Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for FemTech by Offering - Devices, Software, Consumer Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for FemTech by Offering - Percentage Breakdown of Value Sales for Devices, Software, Consumer Products and Services for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for FemTech by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • FemTech Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for FemTech by Offering - Devices, Software, Consumer Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for FemTech by Offering - Devices, Software, Consumer Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for FemTech by Offering - Percentage Breakdown of Value Sales for Devices, Software, Consumer Products and Services for the Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for FemTech by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 104: Rest of World Recent Past, Current & Future Analysis for FemTech by Offering - Devices, Software, Consumer Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Rest of World Historic Review for FemTech by Offering - Devices, Software, Consumer Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Rest of World 16-Year Perspective for FemTech by Offering - Percentage Breakdown of Value Sales for Devices, Software, Consumer Products and Services for the Years 2014, 2024 & 2030
    • TABLE 107: Rest of World Recent Past, Current & Future Analysis for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Rest of World Historic Review for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Rest of World 16-Year Perspective for FemTech by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030

IV. COMPETITION